Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, absent, absolute, AG, age, altogether, anaerobic, annum, antibacterial, antibiotic, antifungal, antimicrobial, Area, Arsenal, art, assist, assistance, AstraZeneca, avibactam, AVYCAZ, bacteria, bacterial, Baker, biothreat, caccae, Carlo, ceftazidime, ceftolozane, chain, China, cIAI, cilastatin, circumvented, Clostridium, College, collusion, conceived, concurrent, Cooperation, Cotiviti, crystalline, deprive, deter, deterring, disagree, divert, double, empiric, environment, eravacycline, ertapenem, erythema, Everest, extraordinary, extravasation, faulty, FDASIA, fluorocycline, forgiven, forma, formatted, France, gastrointestinal, German, Germany, goodwill, Harvard, Hearne, Hong, hypoaesthesia, IGNITE, imipenem, indemnity, Indonesia, influence, Inline, intangible, inter, intervention, IRS, Italy, JAMA, Kingdom, Kong, Korea, Landlord, Larry, leukemia, likelihood, Loan, Macau, mainland, Malaysian, margin, marking, Master, mathematical, Mazuski, median, Melinta, mental, Merck, Merger, meropenem, MERREM, Michael, microbiologic, minute, misconduct, mistake, Monte, motivate, multidrug, myeloid, noninferiority, occurrence, older, outbreak, override, PAION, Paratek, patentee, Patheon, pathogen, Paycheck, PCT, peritoneal, perspective, Pfizer, piperacillin, plasma, platform, pneumonia, pose, PPP, premium, PRIMAXIN, pro, project, projected, promissory, QIDP, quantity, recalculating, recapture, RECARBRIO, reexamination, refund, refundable, relebactam, repay, Republic, residual, resistance, resistant, resolution, respiratory, retroactive, Road, salary, SBA, simple, simulation, Singapore, Socialist, Solomkin, Spain, specialist, stronger, strongly, sublease, sublicensing, sudden, suit, Suite, superficial, Surgery, surgical, surrender, swelling, Switzerland, Taiwan, talent, tangible, tazobactam, tetracycline, Tetraphase, Thailand, thereunto, thetaiotaomicron, threatened, tigecycline, Tilly, TOC, tract, travel, Treaty, TTP, tube, twelve, TYGACIL, UK, undiscounted, unforgiven, unsecured, urgent, VABOMERE, vaborbactam, vessel, vi, Vietnam, viewpoint, visit, vitro, VTE, Waltham, Watertown, withholding, XERAVA, ZERBAXA, ZOSYN
Removed:
announced, approach, approve, arranging, ASU, attempted, attestation, CA, center, characterized, Chawla, CI, commonly, continued, converted, criteria, design, detail, detection, deteriorate, discontinuation, disposition, education, escalation, facing, fourth, generate, GIAPREZATM, goal, guidance, hepcidin, hereunto, inadequate, Integrated, interim, invest, iron, Lakhmir, launch, launched, launching, liquidation, local, Milner, modified, Mulroy, negotiated, occurred, orphan, overload, par, pertain, pivotal, planned, point, preference, presently, prevention, proposed, protective, protocol, release, requested, retrospective, separately, sponsor, Squar, statistically, targeted, toxic, transition, transparency, underwriting, underwritten, unqualified, voting, warrant
Filing tables
Filing exhibits
LJPC similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
La Jolla Pharmaceutical Company
San Diego, CA
We consent to the incorporation by reference in Registration Statements (No. 333-214721), (No. 333-221198) and (333-227818) on Form S-3 and (No. 333-184909), (No. 333-193016), (No. 333-207212), (No. 333-214722), (No. 333-221197) and (No. 333-227819) on Form S-8 of La Jolla Pharmaceutical Company of our report dated March 8, 2021 relating to the consolidated financial statements of La Jolla Pharmaceutical Company appearing in this Annual Report on Form 10-K of La Jolla Pharmaceutical Company for the year ended December 31, 2020.
/s/ BAKER TILLY US, LLP
March 8, 2021
San Diego, California